--- title: "References" slug: "references" type: "index" canonical: "bgtcplaybook.document360.io/references" --- > ## Documentation Index > Fetch the complete documentation index at: https://bgtcplaybook.document360.io/llms.txt > Use this file to discover all available pages before exploring further. # References 13 articles ## [REF: Intro to BGTC Playbook](https://bgtcplaybook.document360.io/docs/ref-intro-to-bgtc-playbook.md) Updated on 2025-03-20 | Published on 2024-02-01 1. AMPĀ® Bespoke Gene Therapy Consortium (BGTC). FNIH. (2023, May 31). https://fnih.org/our-programs/AMP/BGTC ## [REF: Platform-based approach for AAV Gene Therapies](https://bgtcplaybook.document360.io/docs/ref-platform-based-approach-for-aav-gene-therapies.md) Updated on 2025-03-20 | Published on 2024-02-01 Platform Technology Approach for AAV & Lenti-based Gene Therapy. ASGCT Liaison Meeting with FDA (2019) (... ## [REF: Formal FDA Meeting Types](https://bgtcplaybook.document360.io/docs/ref-formal-fda-meeting-types.md) Updated on 2025-01-28 | Published on 2024-02-01 Research, C. f. (2017, December). Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products Guidance for Industry. Retrieved from U.S. Food and Drug Administration:... ## [REF: INTERACT Meeting](https://bgtcplaybook.document360.io/docs/ref-interact-meeting.md) Updated on 2025-01-28 | Published on 2024-02-01 Center for Biologics Evaluation and Research. (n.d.). OTP Interact meeting. U.S. Food and Drug Administration.... ## [REF: Pre-IND Meeting](https://bgtcplaybook.document360.io/docs/ref-pre-ind-meeting.md) Updated on 2026-10-27 | Published on 2024-02-01 Learn about Pre-IND meetings. (n.d.). Retrieved March 4, 2023, from... ## [REF: Expedited Pathways & Designations](https://bgtcplaybook.document360.io/docs/ref-expedited-pathways.md) Updated on 2026-02-11 | Published on 2024-02-01 Accelerated Approval | FDA. (2023, February 24). Retrieved from Food and Drug Administration:... ## [REF: IND Submission](https://bgtcplaybook.document360.io/docs/ref-ind-submission.md) Published on 2026-08-05 Module 1 Administrations, N. A. (2023, 04 14). Code of Federal Regulations. Retrieved from https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-25?toc=1 CFR - Code of Federal Regulations... ## [REF: Bioanalytical Testing Considerations](https://bgtcplaybook.document360.io/docs/ref-bioanalytical-testing-considerations.md) Published on 2026-08-13 1. FDA Guidance for Industry: Bioanalytical Method Validation, May 2018 2. FDA Guidance for Industry: Human Gene Therapy for Rare Disease, January 2020 3. BGTC Bioanalytical Strategy, June 2025 4 .... ## [REF: Clinical Trial Planning, Design, Execution](https://bgtcplaybook.document360.io/docs/ref-clinical-trial-planning-design-execution.md) Published on 2026-08-05 Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products; Guidance for Industry. (2015, June). Retrieved from Food and Drug Administration:... ## [REF: IND Maintenance](https://bgtcplaybook.document360.io/docs/ref-ind-maintenance.md) Updated on 2025-02-04 | Published on 2025-02-04 REF: IND Maintenance ## [REF: Patient Engagement and Patient Centricity](https://bgtcplaybook.document360.io/docs/ref-patient-engagement-and-patient-centricity.md) Updated on 2025-02-04 | Published on 2024-02-01 Diversity in Clinical Trials at FDA Gets a Boost From New Law. (2023, January 19). Retrieved from Bloomberg Law:... ## [REF: Study Site Management](https://bgtcplaybook.document360.io/docs/ref-study-site-management.md) Updated on 2025-04-16 | Published on 2024-02-01 Centers of excellence in healthcare institutions. (2017, July 11). Retrieved from NIH.gov: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516836/ Information Sheet: Guidance for Industry. (2021, May).... ## [REF: Long-Term Follow Up](https://bgtcplaybook.document360.io/docs/ref-long-term-follow-up.md) Updated on 2025-01-28 | Published on 2024-02-01 CHMP. (2010, May). Guideline on follow-up of patients administered with gene therapy medicinal products. Retrieved from EMA:...